Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: An EBMT late effects working party study

Journal of Clinical Oncology

Volumn 25, Issue 17, 2007, Pages 2449-2454

  Cohen, Amnon ^a   Rovelli, Attilio ^b   Merlo, Domenico Franco ^b   Van Lint, Maria Teresa ^b   Lanino, Edoardo ^b   Bresters, Dorine ^b   Ceppi, Marcello ^b   Bocchini, Vittorio ^b   Tichelli, André ^b   Socié, Gerard ^b  

^a San Paolo Hospital   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; LEVOTHYROXINE; METHOTREXATE; RADIOACTIVE IODINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; APLASTIC ANEMIA; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECOND CANCER; SEX DIFFERENCE; SOLID TUMOR; THYROID CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; TRANSPLANTATION CONDITIONING;

EID: 34347256791     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.08.9276     Document Type: Article

References (29)

1. Gratwohl A, Baldomero H, Passweg J, et al: Hematopoietic stem cell transplantation for hematological malignancies in Europe. Leukemia 17:941-959, 2003
2. Socié G, Salooja N, Cohen A, et al: Nonmalignant late effects after allogeneic stem cell transplantation. Blood 101:3373-3385, 2003
3. Deeg HJ, Socié G: Malignancies after hematopoietic stem cell transplantation: Many questions, some answers. Blood 91:1833-1844, 1998
4. Witherspoon RP, Fisher LD, Schoch G, et al: Secondary cancer after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 321:784-789, 1989
5. Socié G, Henry-Amar M, Cosset JM, et al: Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 78:277-279, 1991
6. Lowsky R, Upton J, Fyles G, et al: Secondary malignancies after bone marrow transplantation in adults. J Clin Oncol 12:2187-2192, 1994
7. Deeg HJ, Socie G, Henry-Amar M, et al: Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood 87:386-392, 1996
8. Baker KS, Gurney JG, Ness KK, et al: Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: Results from the Bone Marrow Transplant Survivor study. Blood 104:1898-1906, 2004
9. Curtis ER, Rowlings PA, Deeg HJ, et al: Solid cancers after bone marrow transplantation. N Engl J Med 336:897-904, 1997
10. Kolb HJ, Socié G, Duell T, et al: Malignant neoplasms in long-term survivors of bone marrow transplantation. Ann Intern Med 131:738-744, 1999
11. Socié G, Curtis RE, Sobocinski KA, et al: New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 18:348-357, 2000
12. Baker S, DeFor TE, Burns LJ, et al: New malignancies after blood or marrow stem-cell transplantation in children and adults: Incidence and risk factors. J Clin Oncol 21:1352-1358, 2003
13. Bhatia S, Louie AD, Bhatia R, et al: Solid cancers after bone marrow transplantation. J Clin Oncol 19:464-471, 2001
14. Cohen A, Rovelli A, van Lint MT, et al: Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. Bone Marrow Transplant 28:1125-1128, 2001
15. Parkin DM, Whelan SL, Ferlay J, et al: Cancer Incidence in Five Continents, Volume VIII, 1993-1997. Lyon, France, IARC Scientific Publications No. 155, International Agency for Research on Cancer, 2002
16. Lindsey JK: Modeling Frequency and Count Data. Oxford, United Kingdom, Oxford University Press, 1995
17. Schlumberger MJ: Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306, 1998
18. Sherman SI: Thyroid carcinoma. Lancet 361: 501-511, 2003
19. Shore RE: Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res 131:98-111, 1992
20. Ron E, Lubin JH, Shore RE, et al: Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat Res 141:259-277, 1995
21. Sankila R, Garwicz S, Olsen JH, et al: Risk of subsequent malignant neoplasms among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries. J Clin Oncol 14:1442-1446, 1997
22. Beaty O III, Hudson MM, Greenwald C, et al: Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 13:603-609, 1995
23. Acharya S, Sarafoglou K, LaQuaglia M, et al: Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 97:2397-2403, 2003
24. Dores GM, Metayer C, Curtis RE, et al: Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 20:3484-3494, 2002
25. Black P, Straaten A, Gutjahr P: Secondary thyroid carcinoma after treatment for childhood cancer. Med Pediatr Oncol 31:91-95, 1998
26. Gow KW, Lensing S, Hill DA, et al: Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature. J Pediatr Surg 38:1574-1580, 2003
27. Singer PA, Cooper DS, Daniels GH, et al: Treatment guidelines for patients with thyroid nodules and well differentiated thyroid cancer: American Thyroid Association. Arch Intern Med 156:2165-2172, 1996
28. Utiger RD: Follow-up of patients with thyroid carcinoma. N Engl J Med 337:928-930, 1997
29. Guidelines Working Group.Kendall-Taylor P, Guidelines for the management of thyroid cancer. Clin Endocrinol 58:400-402, 2003